Almitrine as a non-ventilatory strategy to improve intrapulmonary shunt in COVID-19 patients
- 1 August 2020
- journal article
- letter
- Published by Elsevier BV in Anaesthesia, Critical Care & Pain Medicine
- Vol. 39 (4), 467-469
- https://doi.org/10.1016/j.accpm.2020.05.013
Abstract
No abstract availableKeywords
Funding Information
- Université de Lorraine
This publication has 5 references indexed in Scilit:
- COVID-19 Does Not Lead to a "Typical" Acute Respiratory Distress SyndromeAmerican Journal of Respiratory and Critical Care Medicine, 2020
- Prone Position for Acute Respiratory Distress Syndrome. A Systematic Review and Meta-AnalysisAnnals of the American Thoracic Society, 2017
- Intravenous Almitrine Bismesylate Reversibly Induces Lactic Acidosis and Hepatic Dysfunction in Patients with Acute Lung InjuryAnesthesiology, 1998
- Almitrine effect on nitric oxide inhalation in adult respiratory distress syndromeThe Lancet, 1993
- Effect of Almitrine on Ventilation-Perfusion Distribution in Adult Respiratory Distress SyndromeAmerican Review of Respiratory Disease, 1988